+919979891672 
Many people with allergic rhinitis have been managing it for years without ever receiving a proper diagnosis. They take an antihistamine when the sneezing starts, use a nasal spray during bad weeks, and accept that certain months are worse than others. The system works well enough — until it doesn’t. Until the antihistamine stops providing the same relief. Until the bad months start outnumbering the good ones. Until the nose is blocked enough to affect sleep every night, or until a doctor mentions that the uncontrolled rhinitis has been driving chronic sinusitis for the past three years.
At Dr Manish Goyal’s ENT clinic in Bodakdev, Ahmedabad, the most common finding in patients who have been “managing” allergic rhinitis for years is that they have never had allergy testing, never understood which specific allergen is driving their immune response, and have been using medications chosen by trial and error. This guide explains what allergic rhinitis treatment actually requires — from the classification system that guides treatment intensity, through the specific interventions that work, to the prevention strategies that reduce the need for treatment in the first place.
Allergic Rhinitis: Why Managing Symptoms Every Day Is Not the Same as Treating the Condition
The ARIA Classification — Matching Treatment to Severity
The Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines provide a classification framework that determines what level of treatment is appropriate. Most patients with allergic rhinitis have never heard of this classification — and most self-managed treatment is chosen without reference to it.
- Intermittent: symptoms fewer than four days per week or fewer than four consecutive weeks per year
- Persistent: symptoms more than four days per week and more than four consecutive weeks — the most common presentation in Ahmedabad
- Mild: symptoms present but not affecting sleep, work, or daily activities. A non-sedating antihistamine taken as needed is appropriate.
- Moderate-to-severe: symptoms affecting sleep, work performance, or daily activities. Intranasal corticosteroid spray used daily is first-line treatment — not a step-up option.
The critical message: most patients with moderate-to-severe persistent allergic rhinitis are undertreated — managing with antihistamines appropriate for mild intermittent rhinitis, and not receiving the nasal corticosteroid spray their symptom severity warrants.
Why Intranasal Corticosteroid Spray Outperforms Antihistamines for Persistent Rhinitis
This is the most important evidence-based distinction in allergic rhinitis treatment — and the one most patients are never told directly.
Antihistamines block the H1 histamine receptor, reducing sneezing, itching, and watery eyes in the early-phase allergic response. They are fast and effective for mild, intermittent symptoms.
Intranasal corticosteroid sprays suppress both the early-phase histamine response and the late-phase eosinophilic inflammation driving nasal congestion, mucosal thickening, and postnasal drip. Multiple head-to-head trials comparing daily intranasal steroids against daily antihistamines for persistent rhinitis consistently show superior outcomes with the spray — especially nasal congestion, which antihistamines barely affect.
The practical reason most patients do not experience this superiority: incorrect technique. Common errors include directing the spray straight back rather than toward the lateral nasal wall, sniffing forcefully after spraying (carrying the drug into the throat), using it only during symptom peaks rather than daily, and stopping after two weeks before full effect appears. The spray requires four to six weeks of consistent daily use. Dr Manish Goyal demonstrates correct technique at the first consultation — this single correction frequently produces the improvement that months of apparently ineffective spray use failed to achieve.
Allergen Testing — The Step That Changes Everything
Without knowing which specific allergen is driving the immune response, every prevention strategy is generic, and immunotherapy cannot be targeted. In Ahmedabad, the most clinically relevant allergens are:
- House dust mites — dominant year-round indoor sensitiser. Patients experience worst symptoms indoors and in the morning after overnight exposure.
- Prosopis juliflora pollen — the invasive mesquite tree produces one of the most potent pollen loads in Gujarat from February to April.
- Alternaria and Aspergillus moulds — peak during and after monsoon, July to September.
- Cockroach allergen — year-round sensitiser in older residential buildings and dense urban areas.
Skin prick testing or specific IgE blood testing confirms which allergens are active — providing the information that makes every subsequent intervention evidence-based rather than a guess.
Prevention Strategies Matched to Confirmed Triggers
For house dust mite allergy:
- Allergen-impermeable mattress and pillow covers — the most effective single intervention
- Wash bed linen weekly at above 60°C
- Keep bedroom humidity below 50 percent — mites cannot reproduce below this threshold
For Prosopis pollen allergy (February to April):
- Keep bedroom windows closed during early morning peak pollen hours
- Start intranasal corticosteroid spray two weeks before the expected season — before symptoms begin, not after
- Shower and change clothes after extended outdoor time during peak season
Preventive pre-exposure saline rinse: A saline rinse performed before going outdoors during a high-allergen period physically coats the nasal mucosa with a layer that traps incoming allergen particles before the IgE-mast cell response is triggered. This is different from using saline to treat congestion after it develops — it is a pre-exposure barrier measure that reduces the allergen load reaching sensitised mucosal surface.
The Allergic March — Why Untreated Rhinitis Becomes a Larger Problem
Allergic rhinitis is not a static condition. Poorly controlled rhinitis contributes to the development of chronic sinusitis, nasal polyps, and — in a subset of patients — new-onset asthma or worsening of pre-existing asthma. This clinical progression is called the allergic march.
The nasal and bronchial mucosa share a continuous inflammatory environment; what inflames the nose chronically eventually affects the lower airways. A patient who achieves good nasal allergy control through the right combination of allergen avoidance, intranasal steroids, and immunotherapy is not just breathing more comfortably — they are reducing the probability of progressive allergic disease that becomes harder to manage with each year of inadequate control.
Occupational Allergic Rhinitis in Ahmedabad’s Working Population
A specific and frequently unidentified form of allergic rhinitis in Ahmedabad affects workers with high allergen exposure — with symptoms linked to work schedule rather than season. Flour dust in food processing, wood dust in furniture manufacturing, chemical sensitizers in the textile and pharmaceutical industries of the GIDC corridor, and grain dust in storage facilities all produce work-triggered allergic rhinitis in sensitised individuals.
The characteristic pattern: symptoms worsen during the working week and improve significantly on weekends and holidays. If rhinitis follows a work schedule rather than a seasonal calendar, an occupational cause should be investigated — this changes the management approach entirely, including consideration of workplace allergen reduction and respiratory protection.
Immunotherapy — The Only Treatment That Changes the Disease
Allergen immunotherapy — delivered as subcutaneous injections or sublingual drops — is the only allergic rhinitis treatment that modifies the underlying immune response rather than managing its symptoms. By gradually exposing the immune system to increasing doses of the confirmed allergen, immunotherapy induces immune tolerance over one to three years.
Clinical outcomes in well-selected patients include a 30 to 40 percent reduction in symptom severity during allergen seasons, reduced medication requirement, prevention of new sensitisations, and reduced probability of asthma development in at-risk patients. Dr Manish Goyal assesses immunotherapy candidacy at the allergy consultation and discusses both injection and sublingual protocols to match the patient’s preference and schedule.
Frequently Asked Questions
Is there a permanent cure for allergic rhinitis?
Allergen immunotherapy produces the closest thing available — immune tolerance that persists for several years after the treatment course is completed in most patients. It is not a cure in the absolute sense, but it produces sustained reduction in reactivity that continues beyond the treatment period. Medical management controls symptoms but produces no lasting change when stopped.
Can allergic rhinitis develop in adulthood?
Yes. Adult-onset allergic rhinitis is common and is frequently triggered by new allergen exposure — moving to a city with different pollen, beginning a new occupation, acquiring a pet. In Ahmedabad, adults who relocate from smaller towns often develop sensitisation to Prosopis pollen and house dust mites within two to three years of arrival.
Why do my antihistamines seem to work less well than they used to?
Antihistamines do not develop pharmacological tolerance. What changes is the nature of symptoms — as ongoing allergen exposure continues, the late-phase inflammatory response that antihistamines do not significantly affect becomes the dominant driver. Nasal congestion accumulates as the dominant symptom, making the antihistamine appear less effective overall. Adding an intranasal corticosteroid spray addresses the late-phase component that antihistamines miss.
How long should I use a nasal corticosteroid spray before deciding it does not work?
Six weeks of correct daily use is the minimum trial period. Most patients abandon the spray in two to three weeks, before its anti-inflammatory effect has accumulated sufficiently. If six weeks of correct daily use produces no improvement, a consultation with Dr Manish Goyal identifies whether technique is the issue, whether a structural component is complicating the picture, or whether the diagnosis needs reassessment.
Can children receive immunotherapy for allergic rhinitis?
Yes — immunotherapy is approved and effective in children from age five onward. Early immunotherapy in allergic children has a specific additional benefit: it reduces the probability of developing asthma. Sublingual immunotherapy (drops placed under the tongue) is generally preferred in younger children over injection protocols. Dr Manish Goyal’s pediatric ENT practice includes allergy assessment and immunotherapy initiation for eligible children.
How do I know if my rhinitis is allergic or non-allergic?
Allergic rhinitis has a clear immune mechanism — positive allergy testing, consistent seasonal or exposure-related triggers, association with other atopic conditions. Non-allergic rhinitis produces identical symptoms without an identifiable allergen trigger and with negative allergy testing. Non-allergic rhinitis is managed differently — it does not respond to antihistamines and is primarily managed with intranasal corticosteroid spray. The distinction matters enormously for treatment, which is why allergy testing is the essential diagnostic step.
The Difference Between Managing It and Actually Treating It
Managing allergic rhinitis means taking an antihistamine indefinitely. Treating allergic rhinitis means identifying the specific allergen, choosing the medication class matched to symptom severity, implementing targeted avoidance, and in appropriate patients, pursuing immunotherapy to reduce the underlying reactivity. The second approach requires one good initial consultation — after which most patients require far less ongoing medication.
Book your allergic rhinitis consultation with Dr Manish Goyal today.
📍 Dr Manish Goyal — 25, Sumangalam Co-op Housing Society, Drive-In Road, opp. Sunset Drive Cinema, Bodakdev, Ahmedabad – 380054 📞 +91 99798 91672 Website: drmanishgoyal.com/appointments/
For more information, click below:
Dr Manish Goyal | ENT Specialist Ahmedabad
No Comments